Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19 - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Clinical Drug Investigation Year : 2021

Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19

Marta Grauso
Rola Abou-Taam
  • Function : Author
Blanche Guillon
Céline Dietrich
  • Function : Author
François Machavoine
  • Function : Author
Nicolas Garcelon
  • Function : Author
Mélanie Briard
  • Function : Author
Hassan Faour
  • Function : Author
Antoine Neuraz
  • Function : Author
Christophe Delacourt
Thierry Molina
  • Function : Author
Guillaume Lezmi

Abstract

Chlorpromazine has been suggested as being potentially useful in patients with coronavirus disease 2019 (COVID-19) on the grounds of its potential antiviral and anti-inflammatory effects.

Dates and versions

hal-04360161 , version 1 (21-12-2023)

Licence

Attribution

Identifiers

Cite

Karine Adel-Patient, Marta Grauso, Rola Abou-Taam, Blanche Guillon, Céline Dietrich, et al.. Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19. Clinical Drug Investigation, 2021, 41 (3), pp.221-233. ⟨10.1007/s40261-021-01001-0⟩. ⟨hal-04360161⟩
18 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More